Celldex Therapeutics Inc CLDX:NASDAQ

RT Quote | Last NASDAQ LS, VOL From CTA | USD
after hours iconAfter Hours: Last | 03/28/24 EDT
41.80quote price arrow down-0.17 (-0.41%)
Volume
75,350
Close
41.97UNCH (UNCH)
Volume
504,360
52 week range
22.11 - 53.18
Loading...
  • Open41.68
  • Day High42.30
  • Day Low41.21
  • Prev Close41.79
  • 52 Week High53.18
  • 52 Week High Date03/04/24
  • 52 Week Low22.11
  • 52 Week Low Date10/30/23

Key Stats

  • Market Cap2.703B
  • Shares Out64.40M
  • 10 Day Average Volume0.98M
  • Dividend-
  • Dividend Yield-
  • Beta1.49
  • YTD % Change5.82

KEY STATS

  • Open41.68
  • Day High42.30
  • Day Low41.21
  • Prev Close41.79
  • 52 Week High53.18
  • 52 Week High Date03/04/24
  • 52 Week Low22.11
  • 52 Week Low Date10/30/23
  • Market Cap2.703B
  • Shares Out64.40M
  • 10 Day Average Volume0.98M
  • Dividend-
  • Dividend Yield-
  • Beta1.49
  • YTD % Change5.82

RATIOS/PROFITABILITY

  • EPS (TTM)-2.91
  • P/E (TTM)-14.43
  • Fwd P/E (NTM)-14.63
  • EBITDA (TTM)-139.034M
  • ROE (TTM)-37.45%
  • Revenue (TTM)6.883M
  • Gross Margin (TTM)-
  • Net Margin (TTM)-2,054.76%
  • Debt To Equity (MRQ)-

EVENTS

  • Earnings Date05/02/2024(est)
  • Ex Div Date-
  • Div Amount-
  • Split Date-
  • Split Factor-

Latest On Celldex Therapeutics Inc

 

Profile

MORE
Celldex Therapeutics, Inc. is a biopharmaceutical company. The Company is focused on exploring the science of mast cell biology and the development of transformative therapeutics for patients. Its drug candidates include monoclonal and bispecific antibodies designed to address mast cell mediated diseases for which available treatments are inadequate. Its Barzolvolimab, a monoclonal antibody that specifically binds the KIT receptor and potently inhibits its activity, which is...
Karen Shoos
Non-Executive Independent Chairman of the Board
Anthony Marucci
President, Chief Executive Officer, Director
Sam Martin CPA
Chief Financial Office, Senior Vice President, Secretary
Tibor Keler Ph.D.
Executive Vice President, Chief Scientific Officer
Address
53 Frontage Road, Suite 220
Hampton, NJ
08827
United States

Top Peers

SYMBOLLASTCHG%CHG
KROS
Keros Therapeutics Inc
66.20UNCHUNCH
DYN
Dyne Therapeutics Inc
28.39UNCHUNCH
RNA
Avidity Biosciences Inc
25.52UNCHUNCH
RCKT
Rocket Pharmaceuticals Inc
26.94UNCHUNCH
RXRX
Recursion Pharmaceuticals Inc
9.97UNCHUNCH